Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase

Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase

US Patent 8535658 · Granted Sep 17, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Enhanced immunogenicity of tumor associated antigens by addition of alphagal epi2016
Enhanced immunogenicity of tumor associated antigens by addition of alphagal epi2016
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galact2016
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galact2016
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galact2016
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galact2016
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galact2016
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galact2016
IDO inhibitors2015
Enhanced immunogenicity of tumor associated antigens by addition of alphagal epi2015
Enhanced immunogenicity of tumor associated antigens by addition of alphagal epi2015
Enhanced immunogenicity of tumor associated antigens by addition of alphagal epi2014